Abstract
A general account of the different types of drug combination was given in this part, Chap. 6, and other references have appeared in other chapters, notably Part I, Chap. 14 and this part, Chaps. 4, 5, 7 and 13.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bishop A, Birkett B (1947) Acquired resistance to paludrine in Plasmodium gallinaceum. Acquired resistance and persistence after passage through the mosquito. Nature 159:884–885
Bruce-Chwatt LJ (ed), Black RH, Canfield CJ, Clyde DF, Peters W, Wernsdorfer W (1981) Chemotherapy of malaria, 2nd edn. WHO, Geneva
Chin W, Contacos PG, Coatney GR, King HK (1966) The evaluation of sulfonamides, alone or in combination with pyrimethamine, in the treament of multi-resistant falciparum malaria. Am J Trop Med Hyg 15:823–829
Merkli B, Richle RW (1980) Studies on the resistance to single and combined antimalarials in the Plasmodium berghei mouse model. Acta Trop (Basel) 37:228–231
Merkli B, Richle R, Peters W (1980) The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei. Ann Trop Med Parasitol 74:1–9
Mitsuhashi S (ed) (1977) R factor drug-resistant plasmid. University of Tokyo Press, Tokyo
Peters W (1965a) Mepacrine-and primaquine-resistant strains of Plasmodium berghei, Vincke and Lips, 1948. Nature 208:693–694
Peters W (1965b) Drug resistance in Plasmodium berghei, Vincke and Lips, 1948. III. Multiple drug resistance. Exp Parasitol 17:97–102
Peters W (1966) Drug responses of mepacrine-and primaquine-resistant strains of Plasmodium berghei, Vincke and Lips, 1948. Ann Trop Med Parasitol 60:25–30
Peters W (1969) Partial inhibition by mepacrine of the development of sulphonamide resistance in Plasmodium berghei. Nature 223:858–859
Peters W (1970) Chemotherapy and drug resistance in malaria. Academic, London
Peters W (1974) Prevention of drug resistance in rodent malaria by the use of drug mixtures. Bull WHO 51:379–383
Peters W, Gregory KG (1973) The chemotherapy of rodent malaria. XVI:primary resistance to mepacrine in the N67 strain of Plasmodium berghei-type parasite. Ann Trop Med Parasitol 67:133–141
Peters W, Portus JH, Robinson BL (1973) The chemotherapy of rodent malaria. XVII:dynamics of drug resistance, part 3. Influence of drug combinations on the development of resistance to chloroquine in P. berghei. Ann Trop Med Parasitol 67:143–154
Peters W, Howells RE, Portus JH, Robinson BL, Thomas S, Warhurst DC (1977a) The chemotherapy of rodent malaria. XXVII:studies on mefloquine (WR 142, 490). Ann Trop Med Parasitol 71:407–418
Peters W, Portus J, Robinson BL (1977b) The chemotherapy of rodent malaria. XXVIII:the development of resistance to mefloquine (WR 142, 490). Ann Trop Med Parasitol 71:419–427
Peters W, Chance ML, Lissner R, Momen H, Warhurst DC (1978) The chemotherapy of rodent malaria. XXX:the enigmas of the “NS lines” of P. berghei. Ann Trop Med Parasitol 72:23–36
Powers KG, Jacobs RL, Good WC, Koontz LC (1969) Plasmodium vinckei:production of chloroquine-resistant strain. Exp Parasitol 26:193–202
Rabinovich SA (1965) Experimental investigations of antimalarial drug Haloquine. III Investigation of the possibility to restrain the development of chemoresistance to chloridine (Daraprim) by combined administration of chloridine with Haloquine. Medskaya Parazit 34:434–439
Ramakrishnan SP, Satya Prakash Choudhury DA (1957) Selection of a strain of Plasmodium berghei highly resistant to chloroquine (“Resochin”). Nature 179:975
Rieckmann KH (1967) A new repository antimalarial agent, CI-564 used in a field trial in New Guinea. Trans R Soc Trop Med Hyg 61:189–198
Rollo IM (1951) A 2:4-diamino pyrimidine in the treatment of proguanil-resistant laboratory malarial strains. Nature 168:332–333
Rollo IM (1952) “Daraprim” resistance in experimental malarial infections. Nature 170:415
Rosario VE (1976) Genetics of chloroquine resistance in malaria parasites. Nature 261:585–586
Rozman RS, Canfield CJ (1979) New experimental antimalarial drugs. Adv Pharmacol Chemother 16:1–43
Sautet J,Aldighieri J, Aldighieri R, Arnaud G, Ausseil M; Rampal C, Castelli C (1959) Etudes sur la production expérimentale de la résistance a divers produits antimalariques d’une souche de Plasmodium berghei. Bull Soc Path Exot Filiales 52:331–345
Schmidt LH, Harrison J, Rossan RN, Vaughan D, Crosby R (1977) Quantitative aspects of pyrimethamine-sulfonamide synergism. Am J Trop Med Hyg 26:837–849
Sevag MG (1964) Prevention of the emergence of antibiotic-resistant strains of bacteria by atabrine. Arch Biochem Biophys 108:85–88
Thompson PE, Bayles A, Olszewski B, Waitz JA (1965) Studies on a dihydrotriazine and a sulfone, alone and in combination, against Plasmodium berghei in mice. Am J Trop Med Hyg 14:198–206
Tigertt WD, Clyde DF (1976) Drug resistance in the human malarias. Antibiot Chemother 20:246–272
Warhurst DC, Killick-Kendrick R (1967) Spontaneous resistance to chloroquine in a strain of rodent malaria (Plasmodium berghei yoelii). Nature 213:1048–1049
Warren GH, Gregory FJ, Healey EMH, Flint SF (1967) Effect of mixtures of atabrine and antibacterial agents on the emergence of resistant strains of Mycobacterium tuberculosis. Nature 215:526–527
Who (1966) WHO Expert Committee on Malaria. 12th Report. WHO Tech Rep Ser :324 (1966)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Peters, W. (1984). Use of Drug Combinations. In: Peters, W., Richards, W.H.G. (eds) Antimalarial Drug II. Handbook of Experimental Pharmacology, vol 68 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69254-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-69254-3_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69256-7
Online ISBN: 978-3-642-69254-3
eBook Packages: Springer Book Archive